These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21283982)

  • 21. Recent advances in chemotherapy for lung cancer.
    Lilenbaum RC
    Curr Opin Pulm Med; 1996 Jul; 2(4):285-9. PubMed ID: 9363153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy for lung cancer: the state of the art in 2009.
    Higgins MJ; Ettinger DS
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1365-78. PubMed ID: 19827996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-induced pulmonary toxicity in breast cancer patients treated with systemic therapy: a systematic literature review.
    Chen S; Ren Y; Dai H; Li Y; Lan B; Ma F
    Expert Rev Anticancer Ther; 2021 Dec; 21(12):1399-1410. PubMed ID: 34672214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy-induced toxicity of the lungs: an overview.
    Charpidou AG; Gkiozos I; Tsimpoukis S; Apostolaki D; Dilana KD; Karapanagiotou EM; Syrigos KN
    Anticancer Res; 2009 Feb; 29(2):631-9. PubMed ID: 19331213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of pulmonary toxicity associated with targeted anticancer therapies.
    Teuwen LA; Van den Mooter T; Dirix L
    Expert Opin Drug Metab Toxicol; 2015; 11(11):1695-707. PubMed ID: 26293379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antineoplastic therapy-induced pulmonary toxicity.
    Sadowska AM; Specenier P; Germonpre P; Peeters M
    Expert Rev Anticancer Ther; 2013 Aug; 13(8):997-1006. PubMed ID: 23984900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular toxicity of targeted therapies.
    Renouf DJ; Velazquez-Martin JP; Simpson R; Siu LL; Bedard PL
    J Clin Oncol; 2012 Sep; 30(26):3277-86. PubMed ID: 22649132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular-targeted drug for non-small cell lung cancer].
    Okamoto I
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():438-42. PubMed ID: 23513880
    [No Abstract]   [Full Text] [Related]  

  • 29. CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity.
    Torrisi JM; Schwartz LH; Gollub MJ; Ginsberg MS; Bosl GJ; Hricak H
    Radiology; 2011 Jan; 258(1):41-56. PubMed ID: 21183492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy for obstructive atelectasis in nonsmall cell lung cancer: Is this a treatment option?
    Naronha V; Pinninti R; Joshi A; Prabhash K
    Indian J Cancer; 2015; 52(3):368-9. PubMed ID: 26905141
    [No Abstract]   [Full Text] [Related]  

  • 31. Pulmonary toxicities from targeted therapies: a review.
    Barber NA; Ganti AK
    Target Oncol; 2011 Dec; 6(4):235-43. PubMed ID: 22076388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of the pulmonary toxicity of cancer chemotherapeutic agents.
    Weiss RB; Trush DM
    Oncol Nurs Forum; 1982; 9(1):16-21. PubMed ID: 6916364
    [No Abstract]   [Full Text] [Related]  

  • 33. Targeted therapies development in the treatment of advanced nonsmall cell lung cancer.
    Gridelli C; Felip E
    J Biomed Biotechnol; 2011; 2011():415641. PubMed ID: 22219656
    [No Abstract]   [Full Text] [Related]  

  • 34. Pulmonary toxicity of antineoplastic drugs.
    Batist G; Andrews JL
    JAMA; 1981 Sep; 246(13):1449-53. PubMed ID: 7265453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary toxicities of molecular targeted antineoplastic agents: a single-center 10-year experience.
    Lee MY; Yoon SY; Kim KH; Lee N; Kim HY; Hwang JH; Won JH
    Korean J Intern Med; 2021 May; 36(3):689-698. PubMed ID: 33412778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy in nonsmall cell lung cancer: a systematic review.
    Maziak DE; Markman BR; MacKay JA; Evans WK;
    Ann Thorac Surg; 2004 Apr; 77(4):1484-91. PubMed ID: 15063303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic Therapy in Nonsmall Cell Lung Cancer and the Role of Biomarkers in Selection of Treatment.
    Lo B; Laurie SA
    Thorac Surg Clin; 2021 Nov; 31(4):399-406. PubMed ID: 34696852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drugs and iatrogenically induced pulmonary toxicity].
    Mihălţan F
    Pneumoftiziologia; 1991; 40(1):15-23. PubMed ID: 1823192
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug-induced pulmonary disease. Part III. Agents used to treat neoplasms or alter the immune system including a brief review of radiation therapy.
    Demeter SL; Ahamd M; Tomashefski JF
    Cleve Clin Q; 1979; 46(3):113-24. PubMed ID: 509715
    [No Abstract]   [Full Text] [Related]  

  • 40. Pulmonary toxicity from novel antineoplastic agents.
    Dimopoulou I; Bamias A; Lyberopoulos P; Dimopoulos MA
    Ann Oncol; 2006 Mar; 17(3):372-9. PubMed ID: 16291774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.